Literature DB >> 28970256

Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury.

Valentina Masola1, Gianluigi Zaza1, Gloria Bellin1, Luigi Dall'Olmo2, Simona Granata1, Gisella Vischini3, Maria Francesca Secchi4, Antonio Lupo1, Giovanni Gambaro3, Maurizio Onisto4.   

Abstract

Heparanase (HPSE) is part of the biologic network triggered by ischemia/reperfusion (I/R) injury, a complication of renal transplantation and acute kidney injury. During this period, the kidney or graft undergoes a process of macrophages recruitment and activation. HPSE may therefore control these biologic effects. We measured the ability of HPSE and its inhibitor, SST0001, to regulate macrophage polarization and the crosstalk between macrophages and HK-2 renal tubular cells during in vitro hypoxia/reoxygenation (H/R). Furthermore, we evaluated in vivo renal inflammation, macrophage polarization, and histologic changes in mice subjected to monolateral I/R and treated with SST0001 for 2 or 7 d. The in vitro experiments showed that HPSE sustained M1 macrophage polarization and modulated apoptosis, the release of damage associated molecular patterns in post-H/R tubular cells, the synthesis of proinflammatory cytokines, and the up-regulation of TLRs on both epithelial cells and macrophages. HPSE also regulated M1 polarization induced by H/R-injured tubular cells and the partial epithelial-mesenchymal transition of these epithelial cells by M1 macrophages. All these effects were prevented by inhibiting HPSE. Furthermore, the inhibition of HPSE in vivo reduced inflammation and M1 polarization in mice undergoing I/R injury, partially restored renal function and normal histology, and reduced apoptosis. These results show for the first time that HPSE regulates macrophage polarization as well as renal damage and repair after I/R. HPSE inhibitors could therefore provide a new pharmacologic approach to minimize acute kidney injury and to prevent the chronic profibrotic damages induced by I/R.-Masola, V., Zaza, G., Bellin, G., Dall'Olmo, L., Granata, S., Vischini, G., Secchi, M. F., Lupo, A., Gambaro, G., Onisto, M. Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury.

Entities:  

Keywords:  SST0001; cytokines; inflammation; kidney

Mesh:

Substances:

Year:  2018        PMID: 28970256     DOI: 10.1096/fj.201700597R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  14 in total

1.  Extracellular Vesicles from Albumin-Induced Tubular Epithelial Cells Promote the M1 Macrophage Phenotype by Targeting Klotho.

Authors:  Yijie Jia; Zongji Zheng; Meng Xue; Shuting Zhang; Fang Hu; Yang Li; Yanlin Yang; Meina Zou; Shuangshuang Li; Ling Wang; Meiping Guan; Yaoming Xue
Journal:  Mol Ther       Date:  2019-06-04       Impact factor: 11.454

2.  Tissue talks: immunophenotype of cells infiltrating the graft explains histological findings and the benefits of belatacept at 10 years.

Authors:  J Furuzawa-Carballeda; N O Uribe-Uribe; J M Arreola-Guerra; R Reyes-Acevedo; M Vilatobá; A López-Toledo; G Mondragón-Salgado; R Chávez-Fernández; F López-Verdugo; G Mondragón-Ramírez; J Alberú
Journal:  Clin Exp Immunol       Date:  2019-04-15       Impact factor: 4.330

Review 3.  Kidney allograft fibrosis: what we learned from latest translational research studies.

Authors:  Simona Granata; Claudia Benedetti; Giovanni Gambaro; Gianluigi Zaza
Journal:  J Nephrol       Date:  2020-03-19       Impact factor: 3.902

4.  Dichotomic role of heparanase in a murine model of metabolic syndrome.

Authors:  Esther Hermano; Françoise Carlotti; Alexia Abecassis; Amichay Meirovitz; Ariel M Rubinstein; Jin-Ping Li; Israel Vlodavsky; Ton J Rabelink; Michael Elkin
Journal:  Cell Mol Life Sci       Date:  2020-10-13       Impact factor: 9.261

Review 5.  Biology of the Heparanase-Heparan Sulfate Axis and Its Role in Disease Pathogenesis.

Authors:  Israel Vlodavsky; Uri Barash; Hien M Nguyen; Shi-Ming Yang; Neta Ilan
Journal:  Semin Thromb Hemost       Date:  2021-04-01       Impact factor: 6.398

6.  Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.

Authors:  Jingyu Xiang; Mijia Lu; Min Shi; Xiaogang Cheng; Kristin A Kwakwa; Jennifer L Davis; Xinming Su; Suzanne J Bakewell; Yuexiu Zhang; Francesca Fontana; Yalin Xu; Deborah J Veis; John F DiPersio; Lee Ratner; Ralph D Sanderson; Alessandro Noseda; Shamim Mollah; Jianrong Li; Katherine N Weilbaecher
Journal:  J Virol       Date:  2022-03-23       Impact factor: 5.103

7.  Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury.

Authors:  Valentina Masola; Gloria Bellin; Gisella Vischini; Luigi Dall'Olmo; Simona Granata; Giovanni Gambaro; Antonio Lupo; Maurizio Onisto; Gianluigi Zaza
Journal:  Oncotarget       Date:  2018-11-16

8.  Circular RNA YAP1 acts as the sponge of microRNA-21-5p to secure HK-2 cells from ischaemia/reperfusion-induced injury.

Authors:  Tao Huang; Yanwei Cao; Hongyang Wang; Qinghai Wang; Jianlei Ji; Xiaoxia Sun; Zhen Dong
Journal:  J Cell Mol Med       Date:  2020-03-11       Impact factor: 5.310

9.  Effects of Farnesiferol B on Ischemia-Reperfusion-Induced Renal Damage, Inflammation, and NF-κB Signaling.

Authors:  Lu Zhang; Xianjun Fu; Ting Gui; Tianqi Wang; Zhenguo Wang; Gerd A Kullak-Ublick; Zhibo Gai
Journal:  Int J Mol Sci       Date:  2019-12-12       Impact factor: 5.923

Review 10.  Endothelial Glycocalyx as a Regulator of Fibrotic Processes.

Authors:  Valentina Masola; Gianluigi Zaza; Arduino Arduini; Maurizio Onisto; Giovanni Gambaro
Journal:  Int J Mol Sci       Date:  2021-03-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.